[1] DUGUID J R, DE LA PAZ R, DEGROOT J. Magnetic resonance imaging of the midbrain in Parkinson's disease[J]. Ann Neurol, 1986, 20(6):744-747. [2] BAUDREXEL S, WITTE T, SEIFRIED C, et al. Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson's disease[J]. Neuroimage, 2011, 55(4):1728-1738. [3] PRAKASH B D, SITOH Y Y, TAN L C, et al. Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease[J]. Parkinsonism Relat Disord, 2012, 18(9):1029-1033. [4] LANGKAMMER C, PIRPAMER L, SEILER S, et al. Quantitative susceptibility mapping in parkinson's disease[J]. PLoS One, 2016, 11(9):e0162460. [5] AU W L, ADAMS J R, TROIANO A, et al. Neuroimaging in Parkinson's disease[J]. J Neural Transm Suppl, 2006, (70):241-248. [6] TAMBASCO N, PELLICCIOLI G P, CHIARINI P, et al. Magnetization transfer changes of grey and white matter in Parkinson's disease[J]. Neuroradiology, 2003, 45(4):224-230. [7] WANG M Y, HONG X H, CHANG C F, et al. Simultaneous detection and separation of hyperacute intracerebral hemorrhage and cerebral ischemia using amide proton transfer MRI[J]. Magn Reson Med, 2015, 74(1):42-50. [8] ZAISS M, WINDSCHUH J, GOERKE S, et al. Downfield-NOE-suppressed amide-CEST-MRI at 7 Tesla provides a unique contrast in human glioblastoma[J]. Magn Reson Med, 2017, 77(1):196-208. [9] ZAISS M, WINDSCHUH J, PAECH D, et al. Relaxation-compensated CEST-MRI of the human brain at 7 T:Unbiased insight into NOE and amide signal changes in human glioblastoma[J]. Neuroimage, 2015, 112:180-188. [10] TAO Q, YI P W, WEI G J, et al. Recent progress on the method, principle and application of pH imaging based on chemical exchange saturation transfer mechanism[J]. Chinese J Magn Reson, 2018, 35(4):505-519. 陶泉, 易佩伟, 魏国境, 等. 基于CEST机制的pH成像方法、原理和应用[J]. 波谱学杂志, 2018, 35(4):505-519. [11] ZHANG M, LU J H, CAI C B, et al. Effects of lipids signals on nuclear overhauser enhancement contrast imaging at 7 T[J]. Chinese J Magn Reson, 2015, 32(4):606-617. 张苗, 卢建华, 蔡聪波, 等. 7 T下脂肪对基于NOE的磁共振对比成像的影响[J]. 波谱学杂志, 2015, 32(4):606-617 [12] LI C M, PENG S, WANG R, et al. Chemical exchange saturation transfer MR imaging of Parkinson's disease at 3 Tesla[J]. Eur Radiol, 2014, 24(10):2631-2639. [13] LI C M, WANG R, CHEN H B, et al. Chemical exchange saturation transfer mr imaging is superior to diffusion-tensor imaging in the diagnosis and severity evaluation of Parkinson's disease:A study on substantia nigra and striatum[J]. Front Aging Neurosci, 2015, 7:198. [14] BAGGA P, CRESCENZI R, KRISHNAMOORTHY G, et al. Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency[J]. J Neurochem, 2016, 139(3):432-439. [15] ZAISS M, XU J Z, GOERKE S, et al. Inverse Z-spectrum analysis for spillover-, MT-, and T1-corrected steady-state pulsed CEST-MRI-application to pH-weighted MRI of acute stroke[J]. NMR Biomed, 2014, 27(3):240-252. [16] WINDSCHUH J, ZAISS M, MEISSNER J E, et al. Correction of B1-inhomogeneities for relaxation-compensated CEST imaging at 7 T[J]. NMR Biomed, 2015, 28(5):529-537. [17] SAEED U, COMPAGNONE J, AVIV R I, et al. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes:current and emerging concepts[J]. Transl Neurodegener, 2017, 6:8. [18] VAN ZIJL P C M, LAM W W, XU J D, et al. Magnetization transfer contrast and chemical exchange saturation transfer MRI. Features and analysis of the field-dependent saturation spectrum[J]. Neuroimage, 2017, 168:222-241. [19] ZAISS M, BACHERT P. Chemical exchange saturation transfer (CEST) and MR Z-spectroscopy in vivo:a review of theoretical approaches and methods[J]. Phys Med Biol, 2013, 58(22):R221-R269. [20] GUAN J J, FENG Y Q. Quantitative magnetic resonance imaging of brain iron deposition:comparison between quantitative susceptibility mapping and transverse relaxation rate (R2*) mapping[J]. Journal of Southern Medical University, 2018, 38(3):305-311. 关基景, 冯衍秋. 脑铁沉积的MR定量分析方法:定量磁化率成像与横向弛豫率成像比较[J]. 南方医科大学学报, 2018, 38(3):305-311. [21] GROGER A, KOLB R, SCHAFER R, et al. Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging[J]. PLoS One, 2014, 9(1):e84081. [22] CAI K J, SINGH A, POPTANI H, et al. CEST signal at 2ppm (CEST@2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor[J]. NMR Biomed, 2015, 28(1):1-8. [23] ZU Z L, LOUIE E A, LIN E C, et al. Chemical exchange rotation transfer imaging of intermediate-exchanging amines at 2 ppm[J]. NMR Biomed, 2017, 30(10). doi:10.1002/nbm.3756. |